Tacrolimus-Related Kidney Function Change in Ocular Stem Cell Transplantation

20260 citationsJournal Article

Authors

Cameron B. Reinisch · University of Utah

D.K. Warner · University of Cincinnati

Albert Y. Cheung · Eastern Virginia Medical School

Amit Govil · University of Cincinnati

Joseph Jeffery · Brooke Army Medical Center

Elizabeth Kinosz · Cincinnati Eye Institute

E HOLLAND ·

Abstract

Systemic immunosuppressive therapy with tacrolimus after ocular surface stem cell transplantation is well tolerated and contributes to high graft survival rates with minimal impact on acute and long-term kidney function.

Topics & Keywords

Corneal Surgery and Treatments Ocular Surface and Contact Lens Ocular Oncology and Treatments

UN Sustainable Development Goals

Zero hunger

Publication Details

Published in: Cornea

DOI: 10.1097/ico.0000000000004137

Field-Weighted Citation Impact: 0.00

Command Palette